375
Views
7
CrossRef citations to date
0
Altmetric
Original Research

A comparison of pregnancy prevention programmes in Europe

, , MSc, , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Soraya Machado de Jesus, Rafael Santos Santana & Silvana Nair Leite. (2022) Comparative analysis of the use and control of thalidomide in Brazil and different countries: is it possible to say there is safety?. Expert Opinion on Drug Safety 21:1, pages 67-81.
Read now
Zainab A Rashid, Moawia M Al-Tabakha & Muaed Jamal Alomar. (2020) Proper Counseling and Dispensing of Isotretinoin Capsule Products by Community Pharmacists in UAE: A Simulated Patient Study. Clinical, Cosmetic and Investigational Dermatology 13, pages 405-414.
Read now

Articles from other publishers (5)

Soraya Machado de Jesus, Rafael Santos Santana & Silvana Nair Leite. (2020) The organization, weaknesses, and challenges of the control of thalidomide in Brazil: A review. PLOS Neglected Tropical Diseases 14:8, pages e0008329.
Crossref
Andrea M. Russell, Elaine H. Morrato, Rebecca M. Lovett & Meredith Y. Smith. (2020) Quality of Reporting on the Evaluation of Risk Minimization Programs: A Systematic Review. Drug Safety 43:5, pages 427-446.
Crossref
Mélanie Lelubre, Jamila Hamdani, Christelle Senterre, Karim Amighi, Marion Peres, Marie-Paule Schneider, Olivier Bugnon & Carine De Vriese. (2018) Evaluation of compliance with isotretinoin PPP recommendations and exploration of reasons for non-compliance: Survey among French-speaking health care professionals and patients in Belgium. Pharmacoepidemiology and Drug Safety 27:6, pages 668-673.
Crossref
R. A. Charlton, V. Bettoli, H. J. Bos, A. Engeland, E. Garne, R. Gini, A. V. Hansen, L. T. W. de Jong-van den berg, S. Jordan, K. Klungsøyr, A. J. Neville, A. Pierini, A. Puccini, M. Sinclair, D. Thayer & H. Dolk. (2017) The limitations of some European healthcare databases for monitoring the effectiveness of pregnancy prevention programmes as risk minimisation measures. European Journal of Clinical Pharmacology 74:4, pages 513-520.
Crossref
Elaine Agyemang, Lorna Bailey & John Talbot. (2017) Additional Risk Minimisation Measures for Medicinal Products in the European Union: A Review of the Implementation and Effectiveness of Measures in the United Kingdom by One Marketing Authorisation Holder. Pharmaceutical Medicine 31:2, pages 101-112.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.